The Evolving Classification of Diffuse Gliomas: World Health Organization Updates for 2021
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Evolving Classification of Diffuse Gliomas: World Health Organization Updates for 2021
Authors
Keywords
-
Journal
Current Neurology and Neuroscience Reports
Volume 21, Issue 12, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-11-24
DOI
10.1007/s11910-021-01153-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regional identity of human neural stem cells determines oncogenic responses to histone H3.3 mutants
- (2021) Raul Bardini Bressan et al. Cell Stem Cell
- cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas
- (2020) Daniel J. Brat et al. ACTA NEUROPATHOLOGICA
- Histone H3 wild-type DIPG/DMG overexpressing EZHIP extend the spectrum diffuse midline gliomas with PRC2 inhibition beyond H3-K27M mutation
- (2020) David Castel et al. ACTA NEUROPATHOLOGICA
- cIMPACT‐NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT‐Utrecht meeting on future CNS tumor classification and grading
- (2020) David N. Louis et al. BRAIN PATHOLOGY
- Infant high grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes
- (2020) Matthew Clarke et al. Cancer Discovery
- Infratentorial IDH-mutant astrocytoma is a distinct subtype
- (2020) Rouzbeh Banan et al. ACTA NEUROPATHOLOGICA
- Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis
- (2020) Carol C.L. Chen et al. CELL
- cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAFV600E mutation
- (2019) David W. Ellison et al. ACTA NEUROPATHOLOGICA
- CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas
- (2019) Romain Appay et al. NEURO-ONCOLOGY
- Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course
- (2019) Annika K. Wefers et al. ACTA NEUROPATHOLOGICA
- Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas
- (2019) Ana S. Guerreiro Stucklin et al. Nature Communications
- cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant
- (2018) David N. Louis et al. ACTA NEUROPATHOLOGICA
- cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”
- (2018) Daniel J. Brat et al. ACTA NEUROPATHOLOGICA
- Prognostic relevance of genetic alterations in diffuse lower-grade gliomas
- (2017) Kosuke Aoki et al. NEURO-ONCOLOGY
- Evidence of H3 K27M mutations in posterior fossa ependymomas
- (2016) Marco Gessi et al. ACTA NEUROPATHOLOGICA
- Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway
- (2016) Jason T. Huse et al. ACTA NEUROPATHOLOGICA
- Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology
- (2016) Ibrahim Qaddoumi et al. ACTA NEUROPATHOLOGICA
- Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes
- (2015) David Castel et al. ACTA NEUROPATHOLOGICA
- Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entity
- (2015) Andrey Korshunov et al. ACTA NEUROPATHOLOGICA
- CDKN2ALoss Is Associated With Shortened Overall Survival in Lower-Grade (World Health Organization Grades II–III) Astrocytomas
- (2015) Gerald F. Reis et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Evaluation of Histone 3 Lysine 27 Trimethylation (H3K27me3) and Enhancer of Zest 2 (EZH2) in Pediatric Glial and Glioneuronal Tumors Shows Decreased H3K27me3 inH3F3AK27M Mutant Glioblastomas
- (2013) Sriram Venneti et al. BRAIN PATHOLOGY
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas
- (2013) NATURE GENETICS
- Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma
- (2012) Dominik Sturm et al. CANCER CELL
- Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
- (2012) Jeremy Schwartzentruber et al. NATURE
- Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas
- (2012) Gang Wu et al. NATURE GENETICS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started